27 November 2024

Category: Core Story

There could be more pain before the market actually turns

Newsfeeds are clogged with “the bottom’s here!” narrative and we’re already seeing a significant bump in positivity in the public markets including risk-on assets like cryptocurrency, but are we out of the woods? This stream of social media ‘good news’ and bullish fervor comes as the yield curve inversion is in full swing. It might…

20 July 2022
NioCorp (NB.T) Establishes 38-Year Mine Life at Nebraska Critical Minerals Project

This week we’ve been chatting with gold exploration CEOs who are grumpy about the spot price of Au. But at least most investors know what gold looks like, feels like and what the demand drivers are. Not so, with the critical mineral Niobium. Without context, you might assume it was the name of the next…

14 July 2022
Gold mining in Japan?! 3 junior gold stocks focused on Japan

The nation of Japan has been making headlines recently. Unfortunately not for the best of reasons. The world is still reeling from the assassination of former Prime Minister Shinzo Abe, just two days before the Japanese general election. In elections held on Sunday, the Liberal Democratic Party (the party Abe once led) and its ruling…

12 July 2022
The importance of helium and three stocks to keep your eye on in 2022!

Say, “helium,” and people immediately think party balloons and squeaky voices, but this inert gas is far more purposeful than making your friends giggle with your minion impressions. Among many other things, helium is an integral component when it comes to MRIs, eye surgery, rocket engines, arc welding, nuclear reactors, and superconductivity. For many of…

11 July 2022
Three biotech stocks you may have missed

Kezar Life Sciences Inc. Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends in this market include personalized medicine, drug research, artificial intelligence, big data, and synthetic biology. In total, the biotech market is expected to increase from USD$852.88 billion in 2020,…

5 July 2022
Revive Therapeutics (RVV.C) clears FDA hurdles

Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S. citizen spends $1,200 per year on prescription medicines, while people in other western countries spend an average of $550/year. Public health data indicates that the gluttony…

28 June 2022
Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains

Special Delivery Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of orally-delivered drugs, DehydraTECH has demonstrated effectiveness in improving delivery through human skin for the potential development of topically-administered products such as patches. Through various animal studies evaluating the quantity…

28 June 2022
Sandstorm Gold acquires Nomad Royalty. Is this the best way to invest in precious metals?

It is no secret that we here at Equity Guru are big fans of Nomad Royalty (NSR.TO). Earlier this year, we covered why this royalty and streamer company deserves your full attention as they closed a $95 million deal with Greenstone Gold Mines. Nomad Royalty had a great 2021, and kicked off the year strong:…

28 June 2022
Today’s Idea: VERSES Technologies Inc. sets the stage for Web 3.0

Futuristic Shock & Awe As a kid, we all grew up fantasizing about the day we could finally immerse ourselves in a virtual world. Movies like Ready Player One or shows like Sword Art Online popularized the idea of making reality our own through the use of technology. Today, the same tools we dreamt about…

27 June 2022
Uranium pullback provides opportunity to buy the dip! Searchlight Resources (SCLT.V), Fortune Bay (FOR.V) and enCore Energy (EU.V).

Long term. You have probably heard or read those two words more times than you can remember in the past few days. Stock markets are selling off hard, bond yields are spiking, the US Dollar is rallying, and the financial world awaits the Federal Reserve rate decision. A lot of volatility and a lot of…

16 June 2022